APA (7th ed.) Citation

A, L., R, K., EF, M., & K, C. (2026). Can disease activity and treatment responses be captured by a core set of domains in SLE clinical trials? An analysis of phase III belimumab trial data. Lupus science & medicine, 13(1), . https://doi.org/10.1136/lupus-2025-001928

Chicago Style (17th ed.) Citation

A, Lin, Kandane-Rathnayake R, Morand EF, and Connelly K. "Can Disease Activity and Treatment Responses Be Captured by a Core Set of Domains in SLE Clinical Trials? An Analysis of Phase III Belimumab Trial Data." Lupus Science & Medicine 13, no. 1 (2026). https://doi.org/10.1136/lupus-2025-001928.

MLA (9th ed.) Citation

A, Lin, et al. "Can Disease Activity and Treatment Responses Be Captured by a Core Set of Domains in SLE Clinical Trials? An Analysis of Phase III Belimumab Trial Data." Lupus Science & Medicine, vol. 13, no. 1, 2026, https://doi.org/10.1136/lupus-2025-001928.